Showing results (191-200 of 277) with videos related to
Sort By:
Pageof 28
Bulletin Du Cancer|March 26, 2023
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancerPhilipp Harter, Gerhard Bogner, Luis Chiva, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 7, 2024
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancerRachel Grisham, Bradley J Monk, Els Van Nieuwenhuysen, et al.European Journal of Cancer (Oxford, England : 1990)|October 1, 2021
Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancerIgnace Vergote, Isabelle Ray-Coquard, Daniel M Anderson, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2024
Diagnostic Accuracy of 68Ga-FAPI Versus 18F-FDG PET in Patients with Various MalignanciesNader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.Journal of Medical Genetics|December 4, 2020
Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in BRCA1/2: results of the observational AGO-TR1 study (NCT02222883)Jan Hauke, Philipp Harter, Corinna Ernst, et al.International Journal of Cancer|August 6, 2019
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancerIsabelle Ray-Coquard, David Cibula, Mansoor R Mirza, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2015
Pazopanib Maintenance Therapy in East Asian Women With Advanced Epithelial Ovarian Cancer: Results From AGO-OVAR16 and an East Asian StudyJae-Weon Kim, Sven Mahner, Ling-Ying Wu, et al.European Journal of Cancer (Oxford, England : 1990)|May 28, 2023
PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trialLiselore Loverix, Ignace Vergote, Pieter Busschaert, et al.European Journal of Cancer (Oxford, England : 1990)|March 12, 2024
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancerRomain Boidot, Michael G B Blum, Marie-Pierre Wissler, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 19, 2023
The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial designMelisa Guelhan Inci, Jalid Sehouli, Eva Schnura, et al.Pageof 28